OTC

Strength

20; 10; 2.5 mg/5mL; mg/5mL; mg/5mL

NDC

28595080416

Classification

Generic

Dosage Form

SYRUP

Route

ORAL

Last Updated

12/17/2025

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M012

On Market Since

3/19/2014

Pharmacological Classes

Adrenergic alpha1-Agonists
Sigma-1 Agonist
Sigma-1 Receptor Agonists
Uncompetitive N-methyl-D-aspartate Receptor Antagonist
Uncompetitive NMDA Receptor Antagonists
alpha-1 Adrenergic Agonist

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+0.2%

1Y

+1.0%

3Y

+1.7%

5Y

+1.7%

All

+1.7%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.